Wells Fargo
MAIA icon

Wells Fargo’s MAIA Biotechnology MAIA Stock Holding History

Wells Fargo’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-91
Closed -$200 – 7233
2024
Q1 		$200 Buy
91
+22
+32% +$33 ﹤0.01% 6494
2023
Q4 		$81 Buy
69
+6
+10% +$10 ﹤0.01% 6820
2023
Q3 		$139 Buy
63
+29
+85% +$57 ﹤0.01% 6677
2023
Q2 		$75 Buy
34
+20
+143% +$53 ﹤0.01% 6941
2023
Q1 		$48 Hold
14
– – ﹤0.01% 7121
2022
Q4 		$49 Hold
14
– – ﹤0.01% 7010
2022
Q3 		$0 Buy
+14
New +$59 ﹤0.01% 7076

Other funds holding MAIA

HFF
Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Wells Fargo's MAIA Position: Q2 2024 in Review

Wells Fargo sold out of MAIA Biotechnology (MAIA) in Q2 2024, closing a stake of 91 shares — an estimated $200 sold.

Wells Fargo first reported a position in MAIA in Q3 2022 and held it in 7 quarters. The position peaked at $200 in Q1 2024. 21 funds tracked by Wall St. Rank hold MAIA as of Q2 2024.

  • Wells Fargo reported no remaining MAIA Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 91 MAIA Biotechnology shares in Q2 2024, an estimated $200.
  • Wells Fargo first reported a position in MAIA Biotechnology in Q3 2022 and held it in 7 quarters.
  • Wells Fargo's MAIA Biotechnology position peaked at $200 in Q1 2024.
  • 21 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.